A detailed history of 111 Capital transactions in Dexcom Inc stock. As of the latest transaction made, 111 Capital holds 26,004 shares of DXCM stock, worth $1.51 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
26,004
Previous 15,964 62.89%
Holding current value
$1.51 Million
Previous $1.39 Billion 25.57%
% of portfolio
0.33%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$66.46 - $89.53 $667,258 - $898,881
10,040 Added 62.89%
26,004 $1.75 Billion
Q2 2025

Jul 21, 2025

SELL
$59.83 - $87.57 $25,188 - $36,866
-421 Reduced 2.57%
15,964 $1.39 Billion
Q1 2025

May 15, 2025

BUY
$67.74 - $90.75 $1.11 Million - $1.49 Million
16,385 New
16,385 $1.12 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track 111 Capital Portfolio

Follow 111 Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 111 Capital, based on Form 13F filings with the SEC.

News

Stay updated on 111 Capital with notifications on news.